In Virginia, health statistics show more than 20,000 people depend on dialysis and just a few thousand fewer have had kidney ...

Novartis' Fabhalta has become the first treatment approved by the FDA for the ultra-rare kidney disease C3G. But analysts ...

But there's a catch: New research suggests that those blood tests may be unreliable, especially in Black patients. Doctors ...

Nearly 10% of Indians suffer from some kind of kidney malfunction, making chronic kidney disease (CKD) a rising public health ...

Sponsor: Kidneys for Communities Kidney disease is one of the leading causes of death in America, with nearly 100,000 people ...

The US Food and Drug Administration (FDA) has approved iptacopan (Fabhalta) as the first treatment to reduce proteinuria in ...

Addressing patients with chronic kidney disease requires a commitment to data, education, and community, specifically in those affected by social determinants of health (SDOH).

A high-fiving, fist-bumping four-year-old boy is said to be thriving and preparing for school after receiving the "wonderful ...

The use of technicians to assist in delivering dialysis to the end-stage kidney disease population has been a recognized role ...

There's no way to cheat death, but science shows there may be better ways to go than others. DailyMail.com reveals the most ...

Silent diseases cause hidden damage without symptoms. Learn how to detect conditions like hypertension, diabetes, and heart ...